Medicare Part D Gross Spending on GLP-1s Increased Five-Fold Between 2019 and 2024, But Estimated Rebates of Around 50% Mean That Net Spending is Much Lower Gross Medicare Part D spending on GLP-1s in 2024 (not accounting for rebates) totaled $27.5 billion, a five-fold increase from 2019, reflecting an expansion in use of GLP-1s with more recent FDA approvals for type 2 diabetes
Dull, tired-looking skin
The B vitamins in the Myers cocktail IV help your body process those toxins more efficiently, getting your energy levels back on track
Improves Skin Tone and Texture Consistent use leads to an even skin tone, diminished hyperpigmentation, and noticeably smoother, more hydrated skin
In clinical trials, discontinuation rates due to gastrointestinal adverse effects ranged from 3-7%, indicating that whilst most patients can tolerate these symptoms, they can be sufficiently troublesome to necessitate treatment cessation in some cases